Addition of Hemofiltration to Expanded Hemodialysis Improves the Clearance of Large Middle Molecules Without Increasing Transmembrane Pressure or Reducing Serum Albumin

Background: Expanded hemodialysis (HDx) using the medium cut-off membrane Theranova improves clearance of middle and large middle molecules compared to conventional high-flux membranes. Although recent data suggest HDx is not inferior to online hemodiafiltration (HDF) in reducing mortality, convective hemofiltration may further enhance removal of uremic toxins. This study evaluated whether combining HDx with hemofiltration enhances solute removal without increasing TMP or albumin loss compared to HDx alone. Methods: 31 patients on maintenance HD underwent two consecutive dialysis sessions: one with HDx and one with HDxF (50 mL/min, nearly 12 L/session). To minimize sequence bias, we adopted a randomized cross-over design. Reduction ratios (RRs) of urea, creatinine, phosphate, β2-microglobulin (β2-MG), and lambda free light chain (λ-FLC) were calculated to assess solute removal efficiency. We measured the TMP at 60, 120, 180, and 240 minutes during the dialysis session and serum albumin levels before and after HD. Results: The mean age of patients was 49.9 ± 11.6 years, and 64.5% of participants were male (M:F=20:11). The mean dialysis duration was 9.5 ± 8.3 years. There were no significant differences in the RRs of urea, creatinine, phosphate, or β2-MG between HDx and HDxF. However, the RR of λ-FLC was significantly higher with HDxF than HDx only (38.6 ± 10.3% vs. 27.4±10.8%, p < 0.001). Serum albumin levels before and after dialysis were not significantly different in either the HDx group (3.4 ± 0.4 vs. 3.7 ± 0.6, p > 0.05) or the HDxF group (3.6 ± 0.5 vs. 3.7 ± 0.6, p > 0.05). Although TMPs under HDxF were significantly higher than those of HDx only at all measuring points (p < 0.001), they were maintained within the acceptable range of TMP. Conclusion: Compared to HDx alone, HDxF showed better removal of λ-FLC without significantly lowering serum albumin levels. Therefore, HDxF may be a better dialysis modality for reducing cardiovascular complications in HD patients.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025fyhxw32q
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Addition of Hemofiltration to Expanded Hemodialysis Improves the Clearance of Large Middle Molecules Without Increasing Transmembrane Pressure or Reducing Serum Albumin

Chan‐Young Jung, Eun-Ah Yoo, Jai Won Chang, Hyun Ho Choi
Journal of the American Society of Nephrology
Dialysis and Renal Disease Management
article

Addition of Hemofiltration to Expanded Hemodialysis Improves the Clearance of Large Middle Molecules Without Increasing Transmembrane Pressure or Reducing Serum Albumin

Chan‐Young Jung, Eun-Ah Yoo, Jai Won Chang, Hyun Ho Choi
article en

Abstract

Background: Expanded hemodialysis (HDx) using the medium cut-off membrane Theranova improves clearance of middle and large middle molecules compared to conventional high-flux membranes. Although recent data suggest HDx is not inferior to online hemodiafiltration (HDF) in reducing mortality, convective hemofiltration may further enhance removal of uremic toxins. This study evaluated whether combining HDx with hemofiltration enhances solute removal without increasing TMP or albumin loss compared to HDx alone. Methods: 31 patients on maintenance HD underwent two consecutive dialysis sessions: one with HDx and one with HDxF (50 mL/min, nearly 12 L/session). To minimize sequence bias, we adopted a randomized cross-over design. Reduction ratios (RRs) of urea, creatinine, phosphate, β2-microglobulin (β2-MG), and lambda free light chain (λ-FLC) were calculated to assess solute removal efficiency. We measured the TMP at 60, 120, 180, and 240 minutes during the dialysis session and serum albumin levels before and after HD. Results: The mean age of patients was 49.9 ± 11.6 years, and 64.5% of participants were male (M:F=20:11). The mean dialysis duration was 9.5 ± 8.3 years. There were no significant differences in the RRs of urea, creatinine, phosphate, or β2-MG between HDx and HDxF. However, the RR of λ-FLC was significantly higher with HDxF than HDx only (38.6 ± 10.3% vs. 27.4±10.8%, p < 0.001). Serum albumin levels before and after dialysis were not significantly different in either the HDx group (3.4 ± 0.4 vs. 3.7 ± 0.6, p > 0.05) or the HDxF group (3.6 ± 0.5 vs. 3.7 ± 0.6, p > 0.05). Although TMPs under HDxF were significantly higher than those of HDx only at all measuring points (p < 0.001), they were maintained within the acceptable range of TMP. Conclusion: Compared to HDx alone, HDxF showed better removal of λ-FLC without significantly lowering serum albumin levels. Therefore, HDxF may be a better dialysis modality for reducing cardiovascular complications in HD patients.

Journal of the American Society of NephrologyVol. 36(10S)
Asan Medical Center (KR)
Openalex Percentile: Top 65%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.